Streetbeat News

Products Services

PDSB

PDS Biotechnology Corporation (NASDAQ:PDSB) announced the publication of preclinical research and the grant of a U.S. patent for its Infectimune® platform, demonstrating significant advancements in influenza vaccine development. The research showed Infectimune®'s ability to improve the quantity and quality of CD4 T cells, positioning it as a leading candidate for next-generation vaccines. The USPTO granted Patent Number 11,904,015 for vaccine compositions using Infectimune®, enhancing PDS Biotech's intellectual property portfolio.

Portfolio Pulse from Happy Mohamed

March 13, 2024 | 12:04 pm

NRBO

NeuroBo Pharmaceuticals has received approval from the Safety Review Committee to proceed with its Phase 2a clinical trial for DA-1241, a treatment for MASH.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 12:04 pm

CPRX

Catalyst Pharmaceuticals announced the U.S. commercial launch of AGAMREE for Duchenne Muscular Dystrophy (DMD) treatment in patients aged two and older. AGAMREE, approved by the FDA on October 26, 2023, is now available by prescription. It offers a novel alternative to current steroid treatments, potentially reducing side effects and improving quality of life for DMD patients. Catalyst's Pathways Program supports patient access and education. AGAMREE has shown comparable efficacy to standard corticosteroids with a better side effect profile in clinical trials.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 12:01 pm

GOOGL

Google has implemented restrictions on its AI chatbot, Gemini, to limit responses to election-related queries, aiming to prevent misinformation. This move is part of Google's election integrity strategy, especially relevant as India approaches its elections. The restrictions are already in effect in India, where Gemini directs users to Google Search for questions about elections in the U.S., U.K., and South Africa, but still answers queries on Indian politics. This decision aligns with global concerns over AI's role in spreading election misinformation and follows regulatory actions in India requiring tech companies to seek approval before deploying certain AI tools.

Portfolio Pulse from Benzinga Neuro

March 13, 2024 | 12:01 pm

AAPL

GOOG

SPOT

Spotify Technology SA (NYSE:SPOT) is rolling out a beta version of music videos for premium users in 11 markets, featuring artists like Ed Sheeran and Doja Cat. This move, aimed at enhancing user engagement, follows similar offerings by Alphabet Inc.'s (NASDAQ:GOOG) YouTube Music. Spotify's initiative comes amid a subscription fee increase in France due to a new tax and a recent antitrust win against Apple Inc. (NASDAQ:AAPL). Spotify's shares saw a slight decrease of 0.18% to close at $257.62.

Portfolio Pulse from Rounak Jain

March 13, 2024 | 11:52 am

SLDB

Solid Biosciences has entered into a non-exclusive licensing agreement for the use of its proprietary, muscle-targeted AAV-SLB101 capsid.

Portfolio Pulse from Charles Gross

March 13, 2024 | 11:51 am

IONS

Ionis Pharmaceuticals' shares surged following the announcement of positive results from its Phase 2 study of ION224.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:46 am

MU

NVDA

QOWZ

SSNLF

TRFK

Samsung Electronics is adopting a new chip-making technology to compete in the AI chip market, aiming to improve its position against SK Hynix and Micron Technology. SK Hynix leads with over 80% market share in HBM3 chips, supplied mainly to Nvidia, which has seen a 91% stock increase year-to-date due to AI demand. Samsung's shift from NCF to MUF technology is expected to enhance its HBM production yields, which currently lag behind SK Hynix's. Investors can gain exposure to Nvidia through ETFs like QOWZ and TRFK.

Portfolio Pulse from Anusuya Lahiri

March 13, 2024 | 11:44 am

ARCO

Arcos Dorados announced plans to open 80 to 90 new restaurants in 2024, with approximately 90% being free-standing units. The company anticipates total capital expenditures for 2024 to be between $300M and $350M.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:36 am

AGFY

Agrify Corporation (AGFY) has entered into a turnkey extraction equipment deal with Justice Cannabis Co., marking its expansion into the New Jersey market. This partnership signifies Agrify's strategic move to enhance its presence in the rapidly growing cannabis industry by providing state-of-the-art extraction equipment to a leading multi-state operator.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:34 am